Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

I Ordered an Lp(a) Level – Now What?

Canadian Collaborative Research Network

M. O'Donoghue

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

Big Questions About Lipoprotein “Little” (a)

MUSC Cardiology

A. Arana Waring

ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Done!

ACC 2024 Insights

S. Mora

Should Statins Be In the Water?

UPMC

S. Mulukutla

Cardiac CT Angiography: Strengths and Limitations

Canadian Collaborative Research Network

J. Leipsic

Clear Outcomes - The First (and Only) Trial in Statin Intolerant Pat…

MUSC Cardiology

M. Budoff

Targeting Inflammation to Prevent Cardiovascular Disease - Ready for…

National Lipid Association

M. Garshick

How Can CAC Testing Be Used to Inform the Use of Statin and Non-Stat…

Right Care Initiative

D. Lloyd-Jones

Anti-Inflammatory Therapies in Cardiovascular Diseases

Penn Medicine Heart and Vascular Center

A. Abbate

Updates in Lipid Management

Michigan Medicine

S. Hummel

Role of Triglycerides & More

Complex Coronary Cases

R. Rosenson

Zodasiran Silences Hepatic ANGPTL3 Leading to Deep and Durable Reduc…

Robert Rosenson